Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of TRM-1 (TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00094848
Recruitment Status : Completed
First Posted : October 27, 2004
Last Update Posted : August 2, 2013
Sponsor:
Information provided by (Responsible Party):
Human Genome Sciences Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2006
  Actual Study Completion Date : May 2007